Accéder au contenu
Merck

Myrtenal inhibits acetylcholinesterase, a known Alzheimer target.

The Journal of pharmacy and pharmacology (2011-09-09)
Dorothea Kaufmann, Anudeep Kaur Dogra, Michael Wink
RÉSUMÉ

Inhibition of acetylcholinesterase (AChE) is a common treatment for early stages of the most general form of dementia, Alzheimer's disease. In this study selected components of essential oils, which carry a variety of important functional groups, were tested for their in-vitro anti-acetylcholinesterase activity. In-vitro anti-acetylcholinesterase activity was measured by an adapted version of Ellman's colorimetric assay. 1,8-cineole, carvacrol, myrtenal and verbenone apparently inhibited AChE; the highest inhibitory activity was observed for myrtenal (IC50 = 0.17 mm). This is the first study showing the AChE inhibitory activity of myrtenal. Our investigations provided evidence for the efficacy of monoterpenes as inhibitors of AChE.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
(−)-Verbenone, ≥93%
Sigma-Aldrich
(−)-Verbenone, 94%
Supelco
(−)-Verbenone, analytical standard